Ro is making the same FDA-approved GLP-1 medications trusted by celebrities and millionaires available to everyday Americans starting at just $149 per month (even cheaper with insurance!) ...

Digital health company Ro is adding reproductive health to its growing platform with plans to acquire Modern Fertility. The deal, announced Wednesday, is valued north of $225 million, according to ...

Ro, formerly known as Roman, offers telehealth services for hair loss, erectile dysfunction, fertility, and weight loss. The company provides discreet packaging and fast shipping. Ro Body is the brand ...

Telehealth company Ro launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S. The tool could be ...

The direct-to-consumer health-care startup Ro launched a new free tool to help patients determine whether their insurance will cover a class of weight loss and diabetes medications called GLP-1s. Some ...

Ro — formerly called Roman — is a telehealth company offering services for individuals with a number of common health concerns, including erectile dysfunction (ED), fertility, hair loss, weight loss, ...

Ro, a digital elective care and telemedicine provider last valued at $5 billion, announced today that it has acquired Modern Fertility, a reproductive health company founded in 2017. Axios estimates ...

Ro and Pfizer have expanded their generic drug partnership. While the broader alliance should help solidify Ro's position in telehealth, the looming threat of a public-facing Amazon Care rollout could ...

Ro to play critical role in ensuring patients nationwide get access to first and only oral GLP-1 weight loss medication at the lowest available cash price Meet the new GLP-1 pill on Ro "The Wegovy ...

Erectile dysfunction (ED) is more than just a medical condition—it’s a challenge that impacts millions of men’s confidence, relationships, and overall quality of life. Once a topic shrouded in ...

The startup Ro just started prescribing "compounded" semaglutide, an alternative to Ozempic. It's the first big company to do so, despite warnings that the knockoff weight-loss shots could be risky.